Donepezil Adherence, Persistence and Time to First Discontinuation in a Three-Year Follow-Up of Older People

BACKGROUND: Donepezil is indicated for the management of mild to moderate dementia, particularly in Alzheimer's disease. Several studies have described low adherence rates with donepezil. AIM: To examine and measure donepezil adherence, persistence and time to first discontinuation in older New...

Descripción completa

Detalles Bibliográficos
Autores principales: Ndukwe, Henry C., Nishtala, Prasad S.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: S. Karger AG 2015
Materias:
Original Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4777950/
https://www.ncbi.nlm.nih.gov/pubmed/26955381
http://dx.doi.org/10.1159/000441894

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4777950/
https://www.ncbi.nlm.nih.gov/pubmed/26955381
http://dx.doi.org/10.1159/000441894

Ejemplares similares